CARMAT's Aeson® Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe
CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.
News Medical on MSN8h
Machine learning helps predict stroke risk after CF-LVAD implantation
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
Wireless LVAD system could push boundaries of heart device technology
SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...
Machine learning assists in predicting risk of stroke
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...
Armed robbery in Revesby13h
AI Helps Predict Stroke Risk
Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...